Is heavy menstrual bleeding a common cause of iron deficiency and low ferritin in menstruating and perimenopausal women?

Heavy menstrual bleeding (HMB), clinically defined as menstrual blood loss exceeding 80 mL per cycle, is recognized as a primary physiological driver of iron deficiency and low ferritin levels in menstruating and perimenopausal women. As women approach the perimenopausal transition, hormonal fluctuations—specifically erratic estrogen levels and progesterone deficiency—often lead to heavier or more frequent cycles, further depleting iron reserves.

Clinical evidence and prevalence

The relationship between menstrual volume and iron status is well-documented across multiple clinical cohorts.

• Prevalence in HMB: Among women seeking treatment for heavy bleeding, the prevalence of iron deficiency ranges from 45% to 66%.
• Risk Metrics: Research indicates that HMB approximately doubles the risk of developing iron deficiency anemia compared to women with normal menstrual flow.
• Correlation: Studies have demonstrated a clear inverse relationship between menstrual blood loss (MBL) and serum ferritin levels (β = −0.289, p=0.001), where increased volume directly corresponds to lower iron stores.

Mechanistic explanations

Iron deficiency in this population occurs through a direct imbalance between iron loss and replacement.

• Blood Loss vs. Intake: While the average daily iron requirement for men is approximately 1 mg, menstruating women lose an additional 1–2 mg per day during their cycles. When flow is heavy, these losses can far exceed the body's dietary absorption capacity (typically capped at 2–4 mg/day even in states of deficiency).
• Ferritin Depletion: Ferritin serves as the primary storage protein for iron. During periods of chronic heavy bleeding, the body draws upon these stores to maintain hemoglobin production. This results in "non-anemic iron deficiency" (NAID), where ferritin levels fall below 15–30 μg/L while hemoglobin remains temporarily within the normal range.
• Perimenopausal Vulnerability: In women aged 45–55, anovulatory cycles become more common. This leads to a lack of progesterone to stabilize the endometrial lining, resulting in the heavy, prolonged bleeding characteristic of this life stage.

Clinical implications

Given the high correlation between HMB and iron depletion, diagnostic focus is shifting toward proactive screening.

• Screening Standards: Clinical guidelines recommend that women with HMB should be routinely screened for both hemoglobin and ferritin to detect iron depletion before it progresses to clinical anemia.
• Symptom Management: Low ferritin levels, even without anemia, are associated with fatigue, cognitive fog, and reduced physical performance, highlighting the importance of managing both the bleeding and the deficiency simultaneously.

Bottom line

Heavy menstrual bleeding is a major cause of iron deficiency and low ferritin, particularly during the perimenopausal transition. High-volume blood loss exceeds the body's iron absorption capacity, necessitating clinical monitoring of ferritin levels to prevent symptomatic deficiency.